Skip to main content
Lynette Sholl, MD, Pathology, Boston, MA

LynetteMarieShollMD

Pathology Boston, MA

Molecular Genetics, Pulmonary Pathology, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology-Brigham & Women's Hospital, Harvard Medical School

Dr. Sholl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sholl's full profile

Already have an account?

  • Office

    75 Francis Street
    Department of Pathology
    Boston, MA 02115
    Phone+1 617-732-7510

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2004 - 2008
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 2003 - 2004
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2025
  • PA State Medical License
    PA State Medical License 2003 - 2004
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Journal Articles

  • Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid Tumors  
    Jeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
  • PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung Cancers  
    G J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
  • Validation of a Targeted Next-Generation Sequencing Approach to Detect Mismatch Repair Deficiency in Colorectal Adenocarcinoma  
    Lynette M Sholl, Amitabh Srivastava, Neal I Lindeman, Matthew B Yurgelun, Fei Dong, Nature
  • Join now to see all

Authored Content

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018

Press Mentions

  • Computer Platform Helps Match Patients with Cancer to Trials of Targeted Therapy
    Computer Platform Helps Match Patients with Cancer to Trials of Targeted TherapyOctober 12th, 2022
  • Highs, Lows of Tumor Mutation Burden Testing
    Highs, Lows of Tumor Mutation Burden TestingSeptember 20th, 2022
  • Physicians’ Education Resource® to Present a Medical Crossfire®: Optimizing Pathological Assessment in Lung Cancer: A Focus on Patients with EGFR Mutations
    Physicians’ Education Resource® to Present a Medical Crossfire®: Optimizing Pathological Assessment in Lung Cancer: A Focus on Patients with EGFR MutationsJuly 26th, 2019
  • Join now to see all